Your source for content carefully curated for compliance, medical information, and pharmacovigilance professionals. ProPharma Group’s subject matter experts regularly share their expertise in the form of blogs, feedback regarding recent guidance and regulations, case studies, industry trends, and more.
May 14, 2018
What are the real-world consequences of giving inadequate consideration to power when developing a sampling plan? Learn more about "Power and Sample Size" in today's blog by Gary Hyde. Read More
April 3, 2018
Take a closer look at new FDA guidance documents surrounding postmarketing safety reporting (PMSR) requirements. Understand what the documents address, who is impacted, and what this means. Read More